Strategies for Winning Clinical Investigators in a Competitive Marketplace
Pharmaceuticals; Amgen; AAI Development; AstraZeneca; Biologicals
International; Aventis; ICON; Baxter Healthcare; Parexel; Bristol-Myers
Pharmaceuticals; Eli Lilly and Company; Perlegen Sciences;
GlaxoSmithKline; PPD Development; Human Genome Sciences; Janssen; PLIVA
Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
...e effectively financed the continued
development and initial commercialization of PCT with proceeds received
from the liquidation of our investment in panacos
stock, the divestiture of Source Scientific LLC, and the sale of 126,750
shares of our common stock in our private placement co...
New Revolutionary Drug Could Stop the Spread of HIV
...d the science portal EurekAlert.
About 80 percent of people being treated for HIV show resistance to one or more of their drugs, a spokesman for panacos
said. There are several existing ways of tackling HIV.
Many medications work by blocking reverse transcriptase, an enzyme that enables HIV to re...
Panacos in Medical Technology
Panacos in Biological News
Trials for new drug to overcome HIV
...ow resistance to one or more of their drugs, according to Graham Allaway of panacos
Pharmaceuticals in Gaithersburg, Maryland, which is developing PA-457. panacos
hopes to begin trials this month to test how well the drug works in patient...
Panacos in Biological Technology